July 26 (Reuters) - A jury on Friday found that Abbott

Laboratories' ( ABT ) specialized formula for premature infants

caused an Illinois girl to develop a dangerous bowel disease,

ordering the healthcare company to pay $95 million in

compensatory damages.

The verdict in St. Louis, Missouri state court comes in the

first trial against the company out of hundreds of similar

claims over the formula pending in courts around the country,

which Reuters viewed via Courtroom View Network. The jury will

now consider whether to award the girl's mother punitive

damages.